Importantly, tissue specimens from ATC patients show a perfect overlap between miR-146a overexpression and strong NF-κB nuclear staining, indicating that targeting miR-146a is one of the crucial functions of NF-κB in human ATCs [67]. The gene discussed is NFKB1; the disease is Ehlers-Danlos syndrome, musculocontractural type.